Capecitabine News and Research

RSS
New drug combo fights breast cancer with brain metastases

New drug combo fights breast cancer with brain metastases

Patients with advanced HER2-positive breast cancer live longer if treated with pyrotinib, trial shows

Patients with advanced HER2-positive breast cancer live longer if treated with pyrotinib, trial shows

Trastuzumab deruxtecan offers added benefit for patients with HER2-low breast cancer

Trastuzumab deruxtecan offers added benefit for patients with HER2-low breast cancer

New targeted therapy zolbetuximab extends survival for patients with advanced gastric cancer

New targeted therapy zolbetuximab extends survival for patients with advanced gastric cancer

Clinical trial tests effectiveness of chemotherapy after surgery for pancreatic neuroendocrine tumors

Clinical trial tests effectiveness of chemotherapy after surgery for pancreatic neuroendocrine tumors

T-DXd shows high efficacy in HER2-positive breast cancer patients previously treated with T-DM1

T-DXd shows high efficacy in HER2-positive breast cancer patients previously treated with T-DM1

Study estimates the cost-effectiveness of therapeutic alternatives

Study estimates the cost-effectiveness of therapeutic alternatives

Drug combination yields highest response and longest survival rates for patients with pancreatic NETs

Drug combination yields highest response and longest survival rates for patients with pancreatic NETs

Scientists identify a new method to treat triple-negative breast cancer

Scientists identify a new method to treat triple-negative breast cancer

SWOG researchers to present practice-changing research at virtual ASCO 2021

SWOG researchers to present practice-changing research at virtual ASCO 2021

Chemotherapy drugs delivered via nanoparticles could improve bowel cancer survival rates

Chemotherapy drugs delivered via nanoparticles could improve bowel cancer survival rates

Researchers identify genetic markers linked to higher risk of capecitabine-induced hand-foot syndrome

Researchers identify genetic markers linked to higher risk of capecitabine-induced hand-foot syndrome

Immunotherapy benefits patients with gastric and esophageal cancers, new data shows

Immunotherapy benefits patients with gastric and esophageal cancers, new data shows

Trastuzumab emtansine as a preferred second-line choice after horizontal dual blockade

Trastuzumab emtansine as a preferred second-line choice after horizontal dual blockade

Talazoparib did not show overall survival benefit in patients with advanced BRCA-mutated breast cancer

Talazoparib did not show overall survival benefit in patients with advanced BRCA-mutated breast cancer

Expanded Medication Assistance Program increases access to vital cancer therapies

Expanded Medication Assistance Program increases access to vital cancer therapies

Maintenance chemotherapy after initial treatment more beneficial for metastatic colorectal cancer patients

Maintenance chemotherapy after initial treatment more beneficial for metastatic colorectal cancer patients

Treatment combination improves survival in advanced HER2-positive breast cancer patients

Treatment combination improves survival in advanced HER2-positive breast cancer patients

Study: Chemotherapy agent did not improve survival in patients with triple-negative breast cancer

Study: Chemotherapy agent did not improve survival in patients with triple-negative breast cancer

Advances in radiation treatment help prolong, improve lives of people with anal cancer

Advances in radiation treatment help prolong, improve lives of people with anal cancer